Blog
Double-Blind Clinical Trial Shows that Dose Matters with Ketamine in Depressed Patients
The results of a new clinical trial with ketamine were published in Nature's Molecular Psychiatry journal. Researchers conducted a double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression...
The National Institute of Mental Health Highlights Ketamine for Depression
The National Institute of Mental Health (NIMH) issued a highlight on ketamine for treating depression. The most commonly used antidepressants are largely variations on a theme; they increase the supply within synapses of a class of neurotransmitters believed to...
IV Ketamine Shows Promise in Clinical Trial with Depressed Teens
Researchers from the University of Minnesota and The Mayo Clinic found that ketamine caused an average decrease of 42% on the Children’s Depression Rating Scale(CDRS)—the most widely used rating scale in research trials for assessing the severity of depression and...
Yale study found no safety issues with long-term ketamine treatment
Researchers at Yale published a new study titled "Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital" in Clinical Psychiatry. In late 2014, Yale began providing ketamine as an off-label therapy on a case-by-case...
What Fibromyalgia Teaches Us About Chronic Pain
What Fibromyalgia Teaches Us About Chronic Pain Rethinking the Origin of Chronic Pain Until relatively recently, most clinicians (and even many pain researchers) considered the majority of chronic pain to be due to ongoing...
Researchers have discovered the recipe for painlessness
People born with a rare genetic mutation are unable to feel pain, but previous attempts to recreate this effect with drugs have had surprisingly little success. Using mice modified to carry the same mutation, UCL researchers funded by the MRC and Wellcome Trust have...
Latest Pain Research News
Scientific breakthroughs happen every day! In an effort to help our patients stay up to speed on the most cutting edge treatment options available for them, our scientists monitor current research and publish weekly research updates. The title of each article below...
New research reveals that greater frequency and duration of daytime napping are associated with more severe symptomatology in patients with fibromyalgia.
New research reveals that greater frequency and duration of daytime napping are associated with more severe symptomatology in patients with fibromyalgia. According to the study results, published in BMC Musculoskeletal Disorders (2015 Feb 7;16:13. doi: 10.1186/...
Ketamine May Reduce Chronic Pain in Adolescents
Ketamine May Reduce Chronic Pain in Adolescents Subanesthetic ketamine infusions are a safe and effective way to relieve chronic pain in adolescents, a new study suggests. Ketamine, a Schedule III drug, has been used successfully to treat various chronic pain...
Signal Activity Data May Unlock Some Answers Behind Causes of Neuropathic Pain
Clinicians seeking greater understanding of the neural activity behind pain can turn to the results of a University of Western Ontario study, which identified variations in neural activity associated with pain processing between control and neuropathic pain groups....
Weekly Breaking Pain Research Updates
Weekly Breaking Research Updates Scientific breakthroughs happen every day! In an effort to help our patients stay up to speed on the most cutting edge treatment options available for them, our scientists monitor current research and publish weekly research updates. ...
Latest Pain Research News!
Weekly Breaking Research Updates Scientific breakthroughs happen every day! In an effort to help our patients stay up to speed on the most cutting edge treatment options available for them, our scientists monitor current research and publish weekly research updates. ...
Double-Blind Clinical Trial Shows that Dose Matters with Ketamine in Depressed Patients
The results of a new clinical trial with ketamine were published in Nature's Molecular Psychiatry journal. Researchers conducted a double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression...
The National Institute of Mental Health Highlights Ketamine for Depression
The National Institute of Mental Health (NIMH) issued a highlight on ketamine for treating depression. The most commonly used antidepressants are largely variations on a theme; they increase the supply within synapses of a class of neurotransmitters believed to...
IV Ketamine Shows Promise in Clinical Trial with Depressed Teens
Researchers from the University of Minnesota and The Mayo Clinic found that ketamine caused an average decrease of 42% on the Children’s Depression Rating Scale(CDRS)—the most widely used rating scale in research trials for assessing the severity of depression and...
Yale study found no safety issues with long-term ketamine treatment
Researchers at Yale published a new study titled "Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital" in Clinical Psychiatry. In late 2014, Yale began providing ketamine as an off-label therapy on a case-by-case...
What Fibromyalgia Teaches Us About Chronic Pain
What Fibromyalgia Teaches Us About Chronic Pain Rethinking the Origin of Chronic Pain Until relatively recently, most clinicians (and even many pain researchers) considered the majority of chronic pain to be due to ongoing...
Researchers have discovered the recipe for painlessness
People born with a rare genetic mutation are unable to feel pain, but previous attempts to recreate this effect with drugs have had surprisingly little success. Using mice modified to carry the same mutation, UCL researchers funded by the MRC and Wellcome Trust have...
Latest Pain Research News
Scientific breakthroughs happen every day! In an effort to help our patients stay up to speed on the most cutting edge treatment options available for them, our scientists monitor current research and publish weekly research updates. The title of each article below...
New research reveals that greater frequency and duration of daytime napping are associated with more severe symptomatology in patients with fibromyalgia.
New research reveals that greater frequency and duration of daytime napping are associated with more severe symptomatology in patients with fibromyalgia. According to the study results, published in BMC Musculoskeletal Disorders (2015 Feb 7;16:13. doi: 10.1186/...
Ketamine May Reduce Chronic Pain in Adolescents
Ketamine May Reduce Chronic Pain in Adolescents Subanesthetic ketamine infusions are a safe and effective way to relieve chronic pain in adolescents, a new study suggests. Ketamine, a Schedule III drug, has been used successfully to treat various chronic pain...
Signal Activity Data May Unlock Some Answers Behind Causes of Neuropathic Pain
Clinicians seeking greater understanding of the neural activity behind pain can turn to the results of a University of Western Ontario study, which identified variations in neural activity associated with pain processing between control and neuropathic pain groups....
Weekly Breaking Pain Research Updates
Weekly Breaking Research Updates Scientific breakthroughs happen every day! In an effort to help our patients stay up to speed on the most cutting edge treatment options available for them, our scientists monitor current research and publish weekly research updates. ...
Latest Pain Research News!
Weekly Breaking Research Updates Scientific breakthroughs happen every day! In an effort to help our patients stay up to speed on the most cutting edge treatment options available for them, our scientists monitor current research and publish weekly research updates. ...
Double-Blind Clinical Trial Shows that Dose Matters with Ketamine in Depressed Patients
The results of a new clinical trial with ketamine were published in Nature's Molecular Psychiatry journal. Researchers conducted a double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression...
The National Institute of Mental Health Highlights Ketamine for Depression
The National Institute of Mental Health (NIMH) issued a highlight on ketamine for treating depression. The most commonly used antidepressants are largely variations on a theme; they increase the supply within synapses of a class of neurotransmitters believed to...
IV Ketamine Shows Promise in Clinical Trial with Depressed Teens
Researchers from the University of Minnesota and The Mayo Clinic found that ketamine caused an average decrease of 42% on the Children’s Depression Rating Scale(CDRS)—the most widely used rating scale in research trials for assessing the severity of depression and...
Yale study found no safety issues with long-term ketamine treatment
Researchers at Yale published a new study titled "Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital" in Clinical Psychiatry. In late 2014, Yale began providing ketamine as an off-label therapy on a case-by-case...
What Fibromyalgia Teaches Us About Chronic Pain
What Fibromyalgia Teaches Us About Chronic Pain Rethinking the Origin of Chronic Pain Until relatively recently, most clinicians (and even many pain researchers) considered the majority of chronic pain to be due to ongoing...
Researchers have discovered the recipe for painlessness
People born with a rare genetic mutation are unable to feel pain, but previous attempts to recreate this effect with drugs have had surprisingly little success. Using mice modified to carry the same mutation, UCL researchers funded by the MRC and Wellcome Trust have...
Latest Pain Research News
Scientific breakthroughs happen every day! In an effort to help our patients stay up to speed on the most cutting edge treatment options available for them, our scientists monitor current research and publish weekly research updates. The title of each article below...
New research reveals that greater frequency and duration of daytime napping are associated with more severe symptomatology in patients with fibromyalgia.
New research reveals that greater frequency and duration of daytime napping are associated with more severe symptomatology in patients with fibromyalgia. According to the study results, published in BMC Musculoskeletal Disorders (2015 Feb 7;16:13. doi: 10.1186/...
Ketamine May Reduce Chronic Pain in Adolescents
Ketamine May Reduce Chronic Pain in Adolescents Subanesthetic ketamine infusions are a safe and effective way to relieve chronic pain in adolescents, a new study suggests. Ketamine, a Schedule III drug, has been used successfully to treat various chronic pain...
Signal Activity Data May Unlock Some Answers Behind Causes of Neuropathic Pain
Clinicians seeking greater understanding of the neural activity behind pain can turn to the results of a University of Western Ontario study, which identified variations in neural activity associated with pain processing between control and neuropathic pain groups....
Weekly Breaking Pain Research Updates
Weekly Breaking Research Updates Scientific breakthroughs happen every day! In an effort to help our patients stay up to speed on the most cutting edge treatment options available for them, our scientists monitor current research and publish weekly research updates. ...
Latest Pain Research News!
Weekly Breaking Research Updates Scientific breakthroughs happen every day! In an effort to help our patients stay up to speed on the most cutting edge treatment options available for them, our scientists monitor current research and publish weekly research updates. ...
Double-Blind Clinical Trial Shows that Dose Matters with Ketamine in Depressed Patients
The results of a new clinical trial with ketamine were published in Nature's Molecular Psychiatry journal. Researchers conducted a double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression...
The National Institute of Mental Health Highlights Ketamine for Depression
The National Institute of Mental Health (NIMH) issued a highlight on ketamine for treating depression. The most commonly used antidepressants are largely variations on a theme; they increase the supply within synapses of a class of neurotransmitters believed to...
IV Ketamine Shows Promise in Clinical Trial with Depressed Teens
Researchers from the University of Minnesota and The Mayo Clinic found that ketamine caused an average decrease of 42% on the Children’s Depression Rating Scale(CDRS)—the most widely used rating scale in research trials for assessing the severity of depression and...
Yale study found no safety issues with long-term ketamine treatment
Researchers at Yale published a new study titled "Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital" in Clinical Psychiatry. In late 2014, Yale began providing ketamine as an off-label therapy on a case-by-case...
What Fibromyalgia Teaches Us About Chronic Pain
What Fibromyalgia Teaches Us About Chronic Pain Rethinking the Origin of Chronic Pain Until relatively recently, most clinicians (and even many pain researchers) considered the majority of chronic pain to be due to ongoing...
Researchers have discovered the recipe for painlessness
People born with a rare genetic mutation are unable to feel pain, but previous attempts to recreate this effect with drugs have had surprisingly little success. Using mice modified to carry the same mutation, UCL researchers funded by the MRC and Wellcome Trust have...
Latest Pain Research News
Scientific breakthroughs happen every day! In an effort to help our patients stay up to speed on the most cutting edge treatment options available for them, our scientists monitor current research and publish weekly research updates. The title of each article below...
New research reveals that greater frequency and duration of daytime napping are associated with more severe symptomatology in patients with fibromyalgia.
New research reveals that greater frequency and duration of daytime napping are associated with more severe symptomatology in patients with fibromyalgia. According to the study results, published in BMC Musculoskeletal Disorders (2015 Feb 7;16:13. doi: 10.1186/...
Ketamine May Reduce Chronic Pain in Adolescents
Ketamine May Reduce Chronic Pain in Adolescents Subanesthetic ketamine infusions are a safe and effective way to relieve chronic pain in adolescents, a new study suggests. Ketamine, a Schedule III drug, has been used successfully to treat various chronic pain...
Signal Activity Data May Unlock Some Answers Behind Causes of Neuropathic Pain
Clinicians seeking greater understanding of the neural activity behind pain can turn to the results of a University of Western Ontario study, which identified variations in neural activity associated with pain processing between control and neuropathic pain groups....
Weekly Breaking Pain Research Updates
Weekly Breaking Research Updates Scientific breakthroughs happen every day! In an effort to help our patients stay up to speed on the most cutting edge treatment options available for them, our scientists monitor current research and publish weekly research updates. ...
Latest Pain Research News!
Weekly Breaking Research Updates Scientific breakthroughs happen every day! In an effort to help our patients stay up to speed on the most cutting edge treatment options available for them, our scientists monitor current research and publish weekly research updates. ...